TG Therapeutics Provides Business Update and Reports First Quarter 2021 Financial Results

NEXT STORY
Clearside Biomedical Announces Multiple Poster Presentations at the Association for Research in Vision and Ophthalmology 2021 Virtual Meeting
PREV STORY
G1 Therapeutics Initiates Randomized Double Blind Placebo Controlled Phase 2 Study of COSELA™ (trilaciclib) in Non-Small Cell Lung Cancer (PRESERVE 4)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cempra Reports First Quarter 2016 Financial Results and Provides Corporate Update

NDA submissions completed for solithromycin intravenous and oral capsule formulations in the treatment of ...

author_avatar
NASDAQ Market News

Athersys Reports Financial Results for Fourth Quarter, Full Year 2017

Company also announces equity investment and binding letter of intent to expand HEALIOS K.K. collaboration, ...

author_avatar
NASDAQ Market News

GSK Exercises Option over SPEAR T-cell Therapy Program Targeting NY-ESO

PHILADELPHIA and OXFORD, United Kingdom, Sept. 07, 2017 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc ...

author_avatar
NASDAQ Market News